Intra-operative Pancreatoscopy in Patients With IPMN

Running, not enrolling

Conditions studied: Intraductal Papillary Mucinous Neoplasm

In brief

To demonstrate the added value of intraoperative pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant pancreas; to generate a hypothesis for a subsequent randomized control trial.

Key facts

Study ID

NCT03729453

Run by

Boston Scientific Corporation

People needed

100

Starts

2019-03-20

Expected to finish

2027-05-01

Last updated by the study team

2026-07-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient scheduled for surgery for suspected MD-IPMN or Mixed IPMN within 4-6 weeks of enrollment
• Diameter of pancreatic main duct >5mm on pre-operative MRI or CT
• Written informed consent from patient to participate in the study, including compliance with study procedures

You may not qualify if…

• Contraindication for pancreatoscopy
• Age: less than 18 years
• Pregnant women, evaluated per local clinical standard

Where it is running

• University of Colorado Hospital — Denver, Colorado, United States
• Indiana University Health — Indianapolis, Indiana, United States
• Johns Hopkins Hospital University — Baltimore, Maryland, United States
• The First Affiliated Hospital of Nanjing Medical University — Nanjing, China
• Asian Institute of Gastroenterology — Hyderabad, India
• Kansai Medical University — Hirakata, Osaka, Japan
• Academic Medical Center — Amsterdam, Netherlands
• University Hospital of UMEA — Umeå, Sweden

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.